A Study of LY3537031 in Overweight, Obese, and Healthy Participants

NCT06606106 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: LY3537031
DRUG: Placebo

Sponsor

Eli Lilly and Company